Anúncio
Anúncio
ORMP
Oramed Pharmaceuticals Inc.
2.91
USDPatrocinado
+0.06
+2.18%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
2.99
+0.08
+2.68%
Relatórios de Lucros ORMP
Rácio de surpresa positiva
ORMP separação 11 de 15 últimas estimativas.
73%
Próximo Relatório
Próxima semana
Data do Próximo Relatório
08 de jan. de 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q1 25 (Revenue/ EPS)
--
/--
Oramed Pharmaceuticals Inc. earnings per share and revenue
On 13 de nov. de 2025, ORMP reported earnings of 1.12 USD per share (EPS) for Q3 25, beating the estimate of -0.04 USD, resulting in a 2845.10% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.92% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Oramed Pharmaceuticals Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Oramed Pharmaceuticals Inc. reported EPS of $1.12, beating estimates by 2845.1%, and revenue of $0.00, 0% as expectations.
How did the market react to Oramed Pharmaceuticals Inc.'s Q3 2025 earnings?
The stock price moved down -2.92%, changed from $2.40 before the earnings release to $2.33 the day after.
When is Oramed Pharmaceuticals Inc. expected to report next?
The next earning report is scheduled for 08 de jan. de 2026.
What are the forecasts for Oramed Pharmaceuticals Inc.'s next earnings report?
Based on --
analistas, Oramed Pharmaceuticals Inc. is expected to report EPS of -- and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio